Immediate Impact
11 by Nobel laureates 28 from Science/Nature 71 standout
Citing Papers
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
2023 Standout
Cervical cancer therapies: Current challenges and future perspectives
2022 Standout
Works of Thomas Reid being referenced
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology–Gynecologic Oncology Group protocol 240)
2015
Improved Survival with Bevacizumab in Advanced Cervical Cancer
2014 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Thomas Reid | 522 | 261 | 788 | 701 | 680 | 79 | 3.3k | |
| Frederick P. Ognibene | 954 | 44 | 810 | 726 | 117 | 68 | 6.7k | |
| Ulrich Abildgaard | 3070 | 77 | 656 | 1369 | 453 | 147 | 6.5k | |
| Auguste Sturk | 768 | 46 | 3553 | 440 | 214 | 52 | 5.3k | |
| Sarfraz Ahmad | 360 | 18 | 781 | 1160 | 998 | 212 | 3.9k | |
| John F. Martin | 902 | 103 | 1436 | 1018 | 406 | 121 | 5.6k | |
| J. Dawes | 886 | 86 | 628 | 681 | 224 | 133 | 3.3k | |
| Søren Risom Kristensen | 585 | 34 | 828 | 568 | 206 | 183 | 3.6k | |
| Nelson N.H. Teng | 140 | 7 | 846 | 985 | 1806 | 110 | 5.1k | |
| Maria Teresa Sandri | 245 | 27 | 1246 | 858 | 240 | 149 | 9.2k | |
| Jing-fei Dong | 3217 | 133 | 1283 | 977 | 136 | 85 | 6.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...